Novartis to Make Pluvicto Radioligand Therapy at Indianapolis Plant
The Swiss drugmaker received FDA approval to expand U.S. production of its closely watched cancer drug Pluvicto,
The Swiss drugmaker received FDA approval to expand U.S. production of its closely watched cancer drug Pluvicto,